vs

Side-by-side financial comparison of bioAffinity Technologies, Inc. (BIAF) and Marathon Bancorp, Inc. (MBBC). Click either name above to swap in a different company.

Marathon Bancorp, Inc. is the larger business by last-quarter revenue ($2.2M vs $1.6M, roughly 1.4× bioAffinity Technologies, Inc.). Marathon Bancorp, Inc. runs the higher net margin — 22.3% vs -197.0%, a 219.3% gap on every dollar of revenue. On growth, Marathon Bancorp, Inc. posted the faster year-over-year revenue change (41.7% vs -27.8%). Marathon Bancorp, Inc. produced more free cash flow last quarter ($1.4M vs $-2.6M). Over the past eight quarters, Marathon Bancorp, Inc.'s revenue compounded faster (20.3% CAGR vs -18.6%).

bioAffinity Technologies, Inc. is a clinical-stage biotechnology firm focused on developing non-invasive in vitro diagnostic tests for early detection of cancer and respiratory diseases. It serves global healthcare markets, with a core mission to deliver accessible, high-accuracy diagnostic solutions that improve patient outcomes and reduce overall healthcare system costs.

Marathon Bancorp, Inc. is a Maryland-based financial holding company that primarily operates through its community bank subsidiary. It offers a full range of retail and commercial banking products including deposit accounts, consumer loans, commercial mortgages, and small business financing, serving individual and small-to-medium enterprise customers across local markets in Maryland.

BIAF vs MBBC — Head-to-Head

Bigger by revenue
MBBC
MBBC
1.4× larger
MBBC
$2.2M
$1.6M
BIAF
Growing faster (revenue YoY)
MBBC
MBBC
+69.5% gap
MBBC
41.7%
-27.8%
BIAF
Higher net margin
MBBC
MBBC
219.3% more per $
MBBC
22.3%
-197.0%
BIAF
More free cash flow
MBBC
MBBC
$4.0M more FCF
MBBC
$1.4M
$-2.6M
BIAF
Faster 2-yr revenue CAGR
MBBC
MBBC
Annualised
MBBC
20.3%
-18.6%
BIAF

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
BIAF
BIAF
MBBC
MBBC
Revenue
$1.6M
$2.2M
Net Profit
$-3.1M
$501.4K
Gross Margin
Operating Margin
-196.9%
26.2%
Net Margin
-197.0%
22.3%
Revenue YoY
-27.8%
41.7%
Net Profit YoY
-5.7%
880.7%
EPS (diluted)
$-3.59
$0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIAF
BIAF
MBBC
MBBC
Q4 25
$1.6M
$2.2M
Q3 25
$1.4M
$2.1M
Q2 25
$1.3M
$1.9M
Q1 25
$1.9M
$1.7M
Q4 24
$2.2M
$1.6M
Q3 24
$2.4M
$1.6M
Q2 24
$2.4M
$1.6M
Q1 24
$2.4M
$1.6M
Net Profit
BIAF
BIAF
MBBC
MBBC
Q4 25
$-3.1M
$501.4K
Q3 25
$-5.1M
$444.3K
Q2 25
$-4.1M
$-332.0K
Q1 25
$-2.7M
$148.4K
Q4 24
$-3.0M
$51.1K
Q3 24
$-2.0M
$174.9K
Q2 24
$-2.1M
$85.8K
Q1 24
$-2.0M
$-631.1K
Operating Margin
BIAF
BIAF
MBBC
MBBC
Q4 25
-196.9%
26.2%
Q3 25
-158.6%
25.5%
Q2 25
-198.2%
-25.7%
Q1 25
-141.7%
11.6%
Q4 24
-133.5%
3.3%
Q3 24
-84.0%
13.4%
Q2 24
-87.1%
4.1%
Q1 24
-80.8%
-53.7%
Net Margin
BIAF
BIAF
MBBC
MBBC
Q4 25
-197.0%
22.3%
Q3 25
-349.3%
20.7%
Q2 25
-319.9%
-18.9%
Q1 25
-143.5%
8.9%
Q4 24
-134.4%
3.2%
Q3 24
-85.1%
10.8%
Q2 24
-88.0%
6.2%
Q1 24
-81.5%
-40.7%
EPS (diluted)
BIAF
BIAF
MBBC
MBBC
Q4 25
$-3.59
$0.19
Q3 25
$-4.74
$0.17
Q2 25
$-0.17
$-0.13
Q1 25
$-0.16
$0.07
Q4 24
$-17.27
$0.02
Q3 24
$-4.84
$0.06
Q2 24
$-0.19
$0.07
Q1 24
$-0.20
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIAF
BIAF
MBBC
MBBC
Cash + ST InvestmentsLiquidity on hand
$6.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$7.3M
$46.9M
Total Assets
$11.0M
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIAF
BIAF
MBBC
MBBC
Q4 25
$6.4M
Q3 25
$7.7M
Q2 25
$802.8K
Q1 25
$444.7K
Q4 24
$1.1M
Q3 24
$756.6K
Q2 24
$801.3K
Q1 24
$2.5M
Stockholders' Equity
BIAF
BIAF
MBBC
MBBC
Q4 25
$7.3M
$46.9M
Q3 25
$8.9M
$46.3M
Q2 25
$-2.1M
$45.7M
Q1 25
$1.4M
$32.0M
Q4 24
$2.6M
$31.7M
Q3 24
$3.1M
$31.6M
Q2 24
$3.4M
$31.3M
Q1 24
$5.3M
$31.4M
Total Assets
BIAF
BIAF
MBBC
MBBC
Q4 25
$11.0M
$248.0M
Q3 25
$11.5M
$246.0M
Q2 25
$4.8M
$238.8M
Q1 25
$5.5M
$236.8M
Q4 24
$6.5M
$217.9M
Q3 24
$6.6M
$216.5M
Q2 24
$6.7M
$219.3M
Q1 24
$8.0M
$225.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIAF
BIAF
MBBC
MBBC
Operating Cash FlowLast quarter
$-2.6M
$1.4M
Free Cash FlowOCF − Capex
$-2.6M
$1.4M
FCF MarginFCF / Revenue
-160.7%
62.3%
Capex IntensityCapex / Revenue
0.0%
0.6%
Cash ConversionOCF / Net Profit
2.82×
TTM Free Cash FlowTrailing 4 quarters
$-9.4M
$3.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIAF
BIAF
MBBC
MBBC
Q4 25
$-2.6M
$1.4M
Q3 25
$-2.5M
$464.0K
Q2 25
$-2.6M
$1.4M
Q1 25
$-1.6M
$849.0K
Q4 24
$-1.7M
$113.6K
Q3 24
$-1.7M
$945.2K
Q2 24
$-1.5M
$416.6K
Q1 24
$-2.3M
$-802.1K
Free Cash Flow
BIAF
BIAF
MBBC
MBBC
Q4 25
$-2.6M
$1.4M
Q3 25
$-2.5M
$456.6K
Q2 25
$-2.7M
$1.3M
Q1 25
$-1.7M
$773.2K
Q4 24
$-1.7M
$105.0K
Q3 24
$-1.7M
$921.6K
Q2 24
$-1.6M
$-1.8M
Q1 24
$-2.4M
$-1.1M
FCF Margin
BIAF
BIAF
MBBC
MBBC
Q4 25
-160.7%
62.3%
Q3 25
-171.8%
21.3%
Q2 25
-209.6%
66.0%
Q1 25
-91.3%
46.3%
Q4 24
-76.0%
6.6%
Q3 24
-73.1%
57.1%
Q2 24
-65.1%
-118.5%
Q1 24
-99.2%
-67.9%
Capex Intensity
BIAF
BIAF
MBBC
MBBC
Q4 25
0.0%
0.6%
Q3 25
0.3%
0.3%
Q2 25
1.1%
9.3%
Q1 25
2.7%
4.5%
Q4 24
0.0%
0.5%
Q3 24
0.4%
1.5%
Q2 24
1.2%
145.2%
Q1 24
1.7%
16.2%
Cash Conversion
BIAF
BIAF
MBBC
MBBC
Q4 25
2.82×
Q3 25
1.04×
Q2 25
Q1 25
5.72×
Q4 24
2.22×
Q3 24
5.40×
Q2 24
4.85×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons